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Abstract
Background: In recent years, the alleviation of acute myocardial ischemia and reperfusion
injury (MI/RI) during myocardial reperfusion has presented a significant clinical challenge.
This study was performed to investigate the effects of fasudil hydrochloride (FH) post-
conditioning on MI/RI and the underlying mechanism.
Methods: Seventy-two rats were randomly divided into four groups: a Sham group, an
ischemia/reperfusion (I/R) group, a fasudil hydrochloride (FH) group, and a fasudil
hydrochloride+PI3K inhibitor (FH+I) group. Myocardial infarct size, cell apoptotic index
(AI), and myocardial tissue expression of Rho-associated coiled-coil containing protein
kinase 1 (ROCK1), Bcl-2, Bcl-2 associated X protein (Bax), caspase-3, Akt and phosphorylated
Akt (P-Akt) were detected.
Results: All these parameters, except Akt expression, were higher in the I/R group than in the
Sham group (p < 0.05). Compared to the I/R group, myocardial infarct size, AI, Bax and
caspase-3 expression were significantly reduced in the FH group (p < 0.05), while Bcl-2
expression was increased (p < 0.05). However, the myocardial infarct size and AI of the FH+I
group were similar to those of the I/R group (p > 0.05). Compared to the FH group, Bcl-2
expression was reduced in the FH+I group, while Bax and caspase-3 expression was in-
creased (p < 0.05). Furthermore, P-Akt expression in the FH group was significantly higher
than that of the I/R group (p < 0.05).
Conclusions: FH post-conditioning alleviated MI/RI, with narrowing of the infarct size and
decreased apoptosis of ischemic cardiocytes. The mechanism was associated with activation of
the PI3K-Akt signaling pathway. (Cardiol J 2013; 20, 2: 197–202)
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Introduction
Acute myocardial infarction (AMI) is a common
acute disease in cardiology with a high mortality
rate [1, 2]. Clearing obstructed vessels rapidly and
effectively is critical for the treatment of AMI [3].
However, reperfusion is closely associated with
metabolic dysfunction and structural damage to the
cardiocytes, which is known as myocardial is-
chemia/reperfusion injury (MI/RI) [4]. Therefore,
alleviating MI/RI during myocardial reperfusion
represents a significant clinical challenge. Re-
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searchers [5] have proposed ischemic pre-condi-
tioning (IPC) to address this issue. But the applica-
tion value of IPC is rare in AMI patients. Ischemic
post-conditioning (IPost) was first demonstrated in
2003 in a study of ischemia/reperfusion in dogs [6]
and its clinical value in protecting the myocardium
and improving prognosis was subsequently verified
[7, 8]. However, the application of IPost is also li-
mited as it is time-consuming and carries numerous
serious complications. In recent years, a variety of
agents such as adenosine, bradykinin (BK) and
erythropoietin have been shown to activate the
same signaling pathways that IPC and IPost media-
te, mitigating MI/RI [9, 10]. This is known as phar-
macological post-conditioning (PPost) [11]. PPost
has become a significant focus of clinical research,
with encouraging application prospects for its con-
venience and effectiveness.
The mechanism underlying MI/RI includes
oxygen free radical injury, calcium overload, endot-
helial dysfunction and cell apoptosis, which is an
important contributing factor. Decreased Bcl-2 and
increased Bcl-2 associated X protein (Bax) induces
opening of the mitochondrial permeability transition
pore (mPTP), resulting in the release of effectors
such as cytochrome c from mitochondria, initiating
the caspase cascade, leading to cell apoptosis [12–
–15]. However, reperfusion injury salvage kinase
(RISK) inhibits apoptosis by blocking the process
[15–17]. During early reperfusion, Rho associated
coiled-coil forming protein kinase (ROCK) was ac-
tivated, suppressing the RISK pathway [18, 19].
Fasudil hydrochloride (FH), which is the first
specific ROCK inhibitor that has been applied in
clinical practice, functions by competing with ATP
for the ATP binding site in the Rho kinase catalytic
domain [20]. Ichinomiya et al. [21] have shown that
high-dose FH preserves post-conditioning against
myocardial infarction via the activation of m-KATP
channels [21]. However, many other specific mech-
anisms about FH postconditioning are still unclear.
So the discovery of more details, for example the
relationship between FH and ROCK expression, FH
and apoptosis, would be valuable. Previously, intra-
venous injection was the most commonly adopted
route of administration, while intracoronary injec-
tion was rare. Researchers [22] have hypothesized
that intracoronary injection might improve the ef-
ficiency of PPost, based on the observation that in-
tracoronary administration of edaravone was more
effective in the protection of the myocardium dur-
ing MI/RI. Increasing experience of percutaneous
interventions in clinical practice makes intracoro-
nary injection possible. Furthermore, it is thought
that direct application of the drug to the target or-
gan will limit the reduction in the drug concentra-
tion due to distribution to various organs, thus great-
ly improving the utilization rate of the drug.
In this study, an in vivo myocardial ischemia
and reperfusion model was established in rats by
ligating the coronary artery with a balloon. Intra-
coronary injection was adopted to test the effective-
ness of FH post-conditioning and to explore the
possible apoptosis mechanism.
Methods
Animals in this work were treated in accor-
dance with all guiding principles in the care and use
of animals. All procedures were approved by the
local ethical committee.
Reagents
Fasudil hydrochloride (HAl077, Chuan Wei, lot-
number 1011051, Tianjin Chase Sun Pharmaceuti-
cal Corporation, China), nitrotetrazolium blue chlo-
ride (NBT, Shanghai Haoran Biotechnologies Cor-
poration, Ltd., China), Rho-associated coiled-coil
containing protein kinase 1 (ROCK1) antibody, Bcl-2
antibody, Bax antibody and caspase-3 antibody
(Abcam Corporation, Ltd., UK), Akt and phospho-
rylated Akt (P-Akt) antibodies (Cell Signal Corpo-
ration, Ltd., US).
Myocardial ischemia and reperfusion model
Healthy and specific pathogen free male Spra-
gue Dawley (SD) rats (n = 72, 250 ± 10 g) were
selected. The animals were provided by the Exper-
imental Animal Center of the Second Military Med-
ical University and maintained in 12 cages (six per
cage) at 23 ± 2°C, and 60–65% relative humidity
and given free access to food and water.
The in vivo myocardial ischemia and reperfu-
sion model was established in rats by the ligating
the coronary artery with a balloon. Animals were
anesthetized and respiration was assisted with
a ventilator. A polyethylene plastic catheter (0.8 mm
internal diameter) connected to the Power Lab
physiological experimental system was inserted
into the right common carotid artery until a char-
acteristic left ventricular pressure wave was ob-
served. The chest was opened via the fourth or fifth
left lateral thoracotomy. The pericardium was
opened and the heart was exposed. A high-pressure
balloon was placed on the left anterior descending
artery (LAD). The myocardial ischemia was per-
formed by ligating the LAD with the balloon (3.0 ×
× 10 mm, 12 atm) with a 6-0 silk suture around the
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LAD at 1 mm distal to the left atrial appendage. The
reperfusion was performed by emptying the balloon
(0 atm) to re-open the LAD.
SD rats (n = 72) were randomly divided into
four groups (18 per group) as follows: (1) The Sham
group: the LAD was encircled by a 6-0 silk suture
without ligation for 180 min; (2) Ischemia/reperfu-
sion (I/R) group: after ligation for 60 min, the pres-
sure was adjusted to 0 atm to restore blood flow for
120 min; (3) Fasudil hydrochloride (FH) group: af-
ter ligation for 60 min, the pressure pump was ad-
justed to 0 atm. A micro-injection pump was connect-
ed to the polyethylene plastic catheter in the right
common carotid artery. The catheter was pulled from
the left ventricle to the aortic root, where the left
ventricular pressure wave disappeared. FH (500 µg/
/mL, dissolved in normal saline) was pumped into
the aortic root (500 µg/kg/min × 5 min), followed
by reperfusion for 115 min; (4) Fasudil hydrochlo-
ride + PI3K inhibitor (FH+I) group: at 10 min be-
fore ligation, the PI3K inhibitor LY-294002 (75 µg/
/mL, dissolved in normal saline) was administered
(dose, 1 mL/kg). Subsequently, animals received
identical treatment to the FH group.
Immunohistochemical analysis
At the end of reperfusion, six SD rats random-
ly selected from each group were sacrificed by cer-
vical vertebra dislocation. Hearts were removed and
washed with normal saline. After being dried with
filter paper, the total ventricle was weighed. The
ventricle was cut into five slices of equal thickness
from the cardiac apex to the cardiac base, in paral-
lel with the atrioventricular groove. Tissue slices
were stained with 0.1% NBT at 37°C (10–20 min)
and excess dye was washed off with normal saline.
Infarcted myocardium was not stained, while non-
infarcted myocardium was stained black. After ac-
quisition of digital photographs, the stained myo-
cardium was removed and the unstained myocardi-
um was weighed. The weight ratio of the infarcted
myocardium to the total ventricle was calculated to
determine the myocardial infarct size.
Terminal deoxy-nucleotidyl transferase-
-mediated dUTP-biotin nick end-labeling
(TUNEL) assay
Another six SD rats were randomly selected
from each group. Myocardial blocks from anterior
wall of left ventricle were cut off, fixed with neu-
tral formalin for 24 hours and embedded in paraf-
fin. Apoptotic cells were detected using terminal
deoxy-nucleotidyl transferase-mediated dUTP nick
end-labeling (TUNEL) assay according to the in-
structions provided by the manufacturer. Normal
myocardial nuclei were stained blue, while apoptotic
nuclei were brown as visualized by general micros-
copy (400 × magnification). Five fields were ran-
domly selected in each section for enumeration of
TUNEL-positive myocytes and total myocytes. The
percentage (%) of TUNEL-positive myocytes was
calculated to represent the apoptotic index.
Western blot analysis
A further six SD rats in each group were ran-
domly selected. Hearts were removed. Total cel-
lular protein isolated from the myocardium was
separated by SDS-PAGE, and transferred to a ni-
trocellulose membrane. Target bands were detect-
ed by immunoblotting with various primary antibod-
ies (ROCK1, Bcl-2, Bax, caspase-3, Akt, P-Akt).
The membranes were probed with horseradish per-
oxidase conjugated secondary antibodies. Immunore-
active bands were visualized by enhanced chemilu-
minescence and quantified by densitometry.
Calculations and statistics
Data is presented as the mean ± SD from at
least three independent experiments. Statistical
analysis was performed with Student’s t-test by
SPSS 17.0 software. A value of p < 0.05 was con-
sidered statistically significant.
Results
1. FH reduced the myocardial infarct size in the
acute myocardial ischemia-reperfusion model
(Fig. 1). In the Sham group, the myocardial in-
farct size was 0. The myocardial infarct sizes
in the FH group (8.62% ± 3.04%) were redu-
ced significantly compared to those of the
I/R group (18.25% ± 5.19%; p < 0.05). There
was no difference in myocardial infarct sizes be-
tween the I/R group and the FH+I group
(16.70% ± 5.80%; p > 0.05).
2. FH decreased apoptosis in cardiocytes follo-
wing reperfusion (Fig. 2). Few apoptotic cells
(7.11% ± 1.24%) were detected in the Sham
group. However, the number of apoptotic cells
significantly increased in the other three gro-
ups (p < 0.05). Compared to the I/R group
(41.12% ± 5.47%), significantly fewer apoptotic
cells were detected in the FH group (28.56% ±
± 2.87%; p< 0.05), although there was no si-
gnificant difference between the I/R group and
the FH+I group (40.40% ± 7.89%; p > 0.05).
3. ROCK1 expression in myocardial tissues was
not influenced by FH (Fig. 3A). Compared to
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Figure 1. Myocardial infarct size in the acute myocardial ischemia-reperfusion model in rats in each group.
FH narrowed the myocardial infarct size. Compared to I/R group; *p < 0.05.
Figure 2. Apoptotic index of cardiocytes in each group. FH decreased apoptosis in ischemic cardiocytes. Compared
to I/R group; *p < 0.05.
Figure 3. Expression of ROCK1, Bcl-2, Bax, Caspase-3, Akt and P-Akt in myocardial tissues in each group by Western
blot. Compared to the Sham group, ROCK1 expression was increased by FH; *p < 0.05 (A). Compared to the
I/R group, FH increased the expression of Bcl-2 and P-Akt in the acute myocardial ischemia reperfusion model (B, F),
while it decreased the expression of Bax and Caspase-3 (C, D), *p < 0.05. Compared to the I/R group, Akt expres-
sions were not influenced by FH, *p > 0.05 (E)
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the Sham group, the ROCK1 protein expres-
sion in the other groups increased significan-
tly (p < 0.05), although there was no statisti-
cally significant difference between these gro-
ups (p > 0.05).
4. FH increased the expression of Bcl-2 in the
acute myocardial ischemia-reperfusion model
(Fig. 3B). There was no significant difference
in Bcl-2 expression between the Sham group
and the I/R group (1.11 ± 0.12; p > 0.05). Com-
pared to the I/R group, Bcl-2 expression was
increased in the FH group (1.76 ± 0.08; p <
< 0.05). Furthermore, no difference was de-
tected between the I/R group and the FH+I
group (1.05 ± 0.12; p > 0.05).
5. FH decreased Bax expression in the acute
myocardial ischemia-reperfusion model
(Fig. 3C). Compared to the Sham group, Bax
expression was significantly increased in the
I/R group (1.75 ± 0.06; p < 0.05). Compared
to the I/R group, Bax expression was decreased
in the FH group (0.98 ± 0.14; p < 0.05). The-
re was no difference between the I/R group and
the FH+I (1.61 ± 0.11) group (p > 0.05).
6. FH decreased the expression of caspase-3 in
the acute myocardial ischemia-reperfusion
model (Fig. 3D). Compared to the Sham group,
caspase-3 expression was significantly incre-
ased in the I/R group (1.32 ± 0.12; p < 0.05).
Compared to the I/R group, caspase-3 expres-
sion was decreased in the FH group (0.97 ±
± 0.06; p < 0.05). No significant difference was
found between the I/R group and the FH+I
group (1.42 ± 0.11; p > 0.05).
7. Akt expression in myocardial tissues was not
influenced by FH (Fig. 3E). There were no si-
gnificant differences in Akt expression betwe-
en the groups.
8. FH promoted the expression of P-Akt in the
acute myocardial ischemia-reperfusion model
(Fig. 3F). Compared to the Sham group, no si-
gnificant differences in P-Akt expression were
detected between the I/R group (1.09 ± 0.06),
and the FH+I group (1.21 ± 0.06; p > 0.05),
while P-Akt expression increased significantly
in the FH group (1.73 ± 0.05; p < 0.05).
Discussion
Ischemia-reperfusion injury is a major obsta-
cle to the therapy of AMI. The ability to reduce is-
chemia-reperfusion injury represents a clinical chal-
lenge [4]. PPost has gradually become an important
way of alleviating MI/RI, replacing IPC and IPost
with their limited clinical value and numerous com-
plications.
FH is an effective drug to reduce MI/RI. In this
study, we detected that FH significantly narrowed
the myocardial infarct size when ischemic myocar-
dium of rats received reperfusion (Fig. 1). The re-
sult was consistent with that of previous studies
concerning fasudil post-conditioning [21], verifying
that FH preserved post-conditioning against myo-
cardial infarction.
Myocardial ischemia and reperfusion is a com-
plicated pathological process [23–25]. Although FH
has been proved to be able to activate m-KATP
channels to induce PPost [21], many other mecha-
nisms are still valuable. As the inhibitor of ROCK,
FH plays a heart protection role via inhibiting the
activity of ROCK by competing for the ATP bind-
ing site in the ROCK catalytic domain [20]. ROCK,
which is also known as Rho kinase and Rho-associa-
ted kinase, is the most extensively studied down-
stream target of Rho [26]. Rho/ROCK is widely dis-
tributed in mammalian tissues and cells, and per-
forms molecular switch and signal transduction
functions. Hamid et al. [18] showed that ROCK was
activated during early reperfusion. Inhibition of
ROCK at reperfusion onset limited infarct size
through an Akt/eNOS-dependent mechanism, sug-
gesting that ROCK action at reperfusion may be
deleterious through suppression of the RISK path-
way [18].
In our study, we found that ROCK expression
was upregulated in the acute myocardial ischemia-
reperfusion models, although it was not influenced
by FH (Fig. 3A). So we speculated that FH PPost
was solely associated with the activity of ROCK, not
the expression.
Reperfusion injury salvage kinase (RISK) is
a protein kinase involved in the maintenance of cell
survival. In the early stages of myocardial reperfu-
sion, RISK is activated by a kinase cascade and plays
an important role in myocardial protection by inhib-
iting apoptosis [27]. Apoptosis is an important
mechanism for MI/RI [23–25]. So we studied the
relationship between FH and apoptosis. We found
that FH significantly reduced cell apoptosis in is-
chemia-reperfusion myocardium (Fig. 2). Bcl-2 ex-
pression was increased (Fig. 3B), while Bax and
Caspase-3 expression was decreased (Fig. 3C, D).
However, these were abrogated following treat-
ment with the PI3K inhibitor LY-294002 (Fig. 2,
3B–D), demonstrating that FH PPost was associ-
ated with the activation of PI3K-Akt. PI3K-Akt is
an important part of the RISK signaling pathway,
playing a critical role in heart protection induced by
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ROCK inhibition [18]. Our study showed that the
expression of Akt in ischemia-reperfusion myocar-
dium was not influenced by FH (Fig. 3E), but the phos-
phorylation of Akt was promoted by it (Fig. 3F). This
indicated that FH was able to inhibit cell apoptosis and
protect myocardium against MI/RI via the activation
of PI3K-Akt. And it was thought to be associated with
the suppression of the activity of ROCK.
FH is a novel calcium antagonistic vasodilator
marketed by Asahi Chemical Company in 1994 un-
der the trade name Erill. Currently, it is mainly used
as a vasodilator to treat cerebral vasospasm induced
by subarachnoid hemorrhage, pulmonary hyperten-
sion, and cognition and memory dysfunction in
Alzheimer’s disease.
In this study, we have confirmed the post-con-
ditioning effect of FH and found it was possibly due
to the reduced incidence of apoptosis following rep-
erfusion of myocardiocytes. And the specific molec-
ular mechanism may involve activation of PI3K-Akt
signaling pathway. Therefore, FH may provide
a novel agent for the protection of myocardium in
myocardial ischemia-reperfusion.
Conclusions
FH post-conditioning was able to alleviate MI/RI,
with narrowing of the infarct size and decreased
apoptosis of ischemic cardiocytes. The mechanism
was associated with activation of the PI3K-Akt sig-
naling pathway.
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